Renalytix (RNLXY) Margins & Profitability 2023-2024

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 19.2%
EBITDA Margin: -772.6%
Op. Margin: -784.1%
Net Margin: -905.7%

Op. margin of -784.1% is up 1152.5% YoY — cost efficiency is improving. Net margin at -905.7% and gross margin of 19.2% show how much of each revenue dollar survives to profit.

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit